Elanco Animal Health
ELAN
400 hedge funds and large institutions have $10.9B invested in Elanco Animal Health in 2019 Q4 according to their latest regulatory filings, with 86 funds opening new positions, 139 increasing their positions, 116 reducing their positions, and 56 closing their positions.
54% more first-time investments, than exits
New positions opened: 86 | Existing positions closed: 56
20% more repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 116
10% more capital invested
Capital invested by funds: $9.88B → $10.9B (+$1B)
6% more funds holding
Funds holding: 376 → 400 (+24)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.57% less ownership
Funds ownership: 99.62% → 99.06% (-0.57%)
8% less call options, than puts
Call options by funds: $35M | Put options by funds: $38.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$146M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$85.6M |
| 3 |
Janus Henderson Group
London,
|
+$78.4M |
| 4 |
GCM
Glenview Capital Management
New York
|
+$71.1M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$59.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$230M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$120M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$104M |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
-$58.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$42.3M |
ELAN Hedge Fund Activity: Q4 2019 in Review
400 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q4 2019, worth a combined $10.9B — up 10% from $9.88B a quarter earlier.
Buyers outnumbered sellers: 86 funds opened new ELAN positions and 56 closed out — a net gain of 30 holders — while 139 added to existing stakes and 116 trimmed.
The largest buyer was Amundi Asset Management US, adding an estimated $146M. The largest seller was Morgan Stanley, cutting an estimated $230M.
- 400 institutional investors held Elanco Animal Health (ELAN) as of Q4 2019, up from 376 in Q3 2019.
- Funds reported $10.9B of Elanco Animal Health stock for Q4 2019, up 10% quarter-over-quarter.
- 86 funds opened new Elanco Animal Health positions in Q4 2019 and 56 closed out, a net change of +30 holders.
- The largest Elanco Animal Health buyer in Q4 2019 was Amundi Asset Management US, an estimated $146M added.
- The largest Elanco Animal Health seller in Q4 2019 was Morgan Stanley, an estimated $230M sold.
Based on aggregated 13F filings for Q4 2019.